Viewing Study NCT03352934


Ignite Creation Date: 2025-12-25 @ 2:30 AM
Ignite Modification Date: 2026-02-03 @ 9:14 AM
Study NCT ID: NCT03352934
Status: COMPLETED
Last Update Posted: 2022-02-25
First Post: 2017-11-03
Is Gene Therapy: True
Has Adverse Events: False

Brief Title: Avelumab Treatment in Patients With Neuroendocrine Carcinomas (NEC G3) Progressive After Chemotherapy
Sponsor: Johannes Gutenberg University Mainz
Organization:

Study Modules

Identification Module Status Module Sponsor Collaborators Module Oversight Module Description Module Conditions Module Design Module Arms Interventions Module Outcomes Module Eligibility Module Contacts Locations Module